Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia

Journal of Neurochemistry

Volumn 86, Issue 1, 2003, Pages 238-245

  Michel, Uwe ^a,b   Gerber, Joachim ^b   O'Connor, Anne E ^a   Bunkowski, Stephanie ^b   Brück, Wolfgang ^b   Nau, Roland ^b   Phillips, David J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Activin; Cerebrospinal fluid; Macrophages; Meningitis; Microglia

Indexed keywords

ACTIVIN; FOLLISTATIN; LACTIC ACID; ORITAVANCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CONTROLLED STUDY; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MICROGLIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RABBIT; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SEPTICEMIA; STREPTOCOCCUS PNEUMONIAE;

ACTIVINS; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; BRAIN; CEREBROSPINAL FLUID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MENINGITIS, PNEUMOCOCCAL; MICROGLIA; NEURONS; RABBITS; UP-REGULATION;

ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0038647411     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01834.x     Document Type: Article

References (41)

1. Aloisi F. (2001) Immune function of microglia. Glia 36, 165-179.
2. Böttner M., Krieglstein K. and Unsicker K. (2000) The transforming growth factors: structure, signaling, and roles in nervous system development and functions. J. Neurochem. 75, 2227-2240.
3. Erämaa M., Hurme M., Stenman U.-H. and Ritvos O. (1992) Activin A/erythroid differentiation factor is induced during human monocyte activation. J. Exp. Med. 176, 1449-1452.
4. Gerber J., Brück W., Stadelmann C., Bunkowski S., Lassmann H. and Nau R. (2001a) Expression of death-related proteins in dentate granule cells in human bacterial meningitis. Brain Pathol 11, 422-431.
5. Gerber J., Smirnov A., Wellmer A., Ragheb J., Prange J., Schütz E., Wettich K., Kalich S. and Nau R. (2001b) Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin. Antimicrob. Agents Chemother 45, 2169-2172.
6. Groome N. P. and Lawrence M. (1991) Preparation of monoclonal antibodies to the A subunit of ovarian inhibin using a synthetic peptide immunogen. Hybridoma 10, 309-316.
7. Hübner G., Brauchle M., Gregor M. and Werner S. (1997) Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab. Invest. 77, 311-318.
8. Hughes P. E., Alexi T., Williams C. E., Clark R. G. and Gluckman P. D. (1999) Admnistration of recombinant human activin A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92, 197-209.
9. Iwahori Y., Saito H., Torii K. and Nishiyama N. (1997) Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res. 760, 52-58.
10. Jones K. L., Brauman J. N., Groome N. P., de Kretser D. M. and Phillips D. J. (2000) Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology 141, 1905-1908.
11. Knight P. G., Muttukrishna S. and Groome N. P. (1996) Development and application of a two-site enzyme immunoassay for the determination of 'total' activin A concentrations in serum and follicular fluid. J. Endocrinol. 148, 267-279.
12. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
13. + toxicity. EMBO J. 14, 736-742.
14. Krieglstein K., Strelau J., Schober A., Sullivan A. and Unsicker K. (2002) TGF and the regulation of neuron survival and death. J. Physiol. 96, 25-30.
15. Lai M., Sirimanne E., Williams C. E. and Gluckman P. D. (1996) Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. Neuroscience 70, 1013-1024.
16. Lai M., Gluckman P., Dragunow M. and Hughes P. E. (1997) Focal brain injury increases activin A mRNA expression in hippocampal neurons. Neuroreport 8, 2691-2694.
17. Li Y., Liu L., Barger S. W., Mrak R. E. and Griffin W. S. (2001) Vitamin E suppression of microglial activation is neuroprotective. J. Neurosci. Res. 66, 163-170.
18. Matsuse T., Fukuchi Y., Eto Y., Matsui H., Hosoi T., Oka T., Ohga E., Nagase T. and Orimo H. (1995) Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment. Am. J. Respir. Cell Mol. Biol. 13, 17-24.
19. Merkelbach S., Sittinger H., Schweizer I. and Müller M. (2000) Cognitive outcome after bacterial meningitis. Acta Neurol. Scand. 102, 118-123.
20. Michel U., Schneider O., Kirchhof C., Meisel S., Smirnov A., Wiltfang J. and Rieckmann P. (1996) Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362. Endocrinology 137, 4925-4934.
21. Michel U., Shintani Y. and Nau R. (1998) Serum follistatin concentrations are increased in patients with septicaemia. Clin. Endocrinol. 48, 413-417.
22. Michel U., Ebert S., Schneider O., Shintani Y., Bunkowski S., Smirnov A., Stringaris A. K., Gerber J., Brück W. and Nau R. (2000) Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis. Eur. J. Endocrinol. 143, 809-816.
23. Michel U., Ebert S., Phillips D. J. and Nau R. (2003) Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J. Endocrinol. 148, 559-564.
24. Nau R. and Brück W. (2002) Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 25, 38-45.
25. Nishihara T., Ohsaki Y., Ueda N., Koseki T. and Eto Y. (1995) Induction of apoptosis in B lineage cells by activin A derived from macrophages. J. Interferon Cytokine Res. 15, 509-516.
26. Nüsing R. M., Mohr S. and Ullrich V. (1995) Activin A and retinoic acid synergize in cyclooxygenase-1 and thromboxane synthase induction during differentiation of J774.1 macrophages. Eur J. Biochem. 227, 130-136.
27. O'Connor A. E., McFarlane J. R., Hayward S., Yohkaichiya T., Groome N. P. and de Kretser D. M. (1999) Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum. Reprod. 14, 827-832.
28. Ogawa K., Funaba M., Mathews L. S. and Mizutani T. (2000) Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J. Immunol. 165, 2997-3003.
29. Petraglia F., Sacerdote P., Cossarizza A., Angioni S., Genazzani A. D., Francheschi C., Muscettola M. and Grasso G. (1991) Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon production. J. Clin. Endocrinol. Metab. 72, 496-502.
30. Phillips D. J. (2003) The activin/inhibin family. In: The Cytokine Handbook, 4th edn. (A. Thomson and M. T. Lotze, eds). Academic Press, New York.
31. Phillips D. J., Jones K. L., Scheerlinck J. P. Y., Hedger M. P. and de Kretser D. M. (2001) Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol. Cell. Endocrinol. 180, 155-162.
32. Schubert D., Kimura H., LaCorbiere M., Vaughan J., Karr D. and Fischer W. H. (1990) Activin is a nerve cell survival molecule. Nature 344, 868-870.
33. Shao L.-E., Frigon N. L. Jr, Sehy D. W., Yu A. L., Lofgren J., Schwall R. and Yu J. (1992) Regulation of production of activin A in human marrow stromal cells and monocytes. Exp. Hematol. 20, 1235-1242.
34. Speake T., Whitwell C., Kajita H., Majid A. and Brown P. D. (2001) Mechanisms of CSF secretion by the choroid plexus. Microsc. Res. Techn. 52, 49-59.
35. Tretter Y. P., Hertel M., Munz B., ten Bruggencate G., Werner S. and Alzheimer C. (2000) Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat. Med. 6, 812-815.
36. Woodruff T. K. (1998) Regulation of cellular and system function by activin. Biochem. Pharmacol. 55, 953-963.
37. Wu D. D., Lai M., Hughes P. E., Sirimanne E., Gluckman P. D. and Williams C. E. (1999) Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res. 835, 369-378.
38. Yamada R., Suzuki T., Hashimoto M., Eto Y., Shiokawa K. and Muramatsu M. (1992) Induction of differentiation of the human promyelocytic cell line HL-60 by activin/EDF. Biochem. Biophys. Res. Commun. 187, 79-85.
39. Yrjänheikki J., Keinänen R., Pellikka M., Hökfelt T. and Koistinaho J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl Acad. Sci. USA 95, 15769-15774.
40. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P. H. and Koistinaho J. (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl Acad. Sci. USA 96, 13496-13500.
41. Yu E. W., Dolter K. E., Shao L.-E. and Yu J. (1998) Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin. Exp. Immunol. 112, 126-132.